AEON Biopharma AEON
NYSE AEON
$0.24 0.00 (-0.54%)
As of: Oct 22, 2026 · 3:52 PM EDT

AEON Biopharma (AEON) Return on Capital Employed [ROCE] (2021 - 2025)

Updated

AEON Biopharma's Return on Capital Employed [ROCE] came in at -5121.60% for Q4 2025, down 4633.58 percentage points from the prior quarter.

Analysis

AEON Biopharma (AEON) Return on Capital Employed [ROCE] (2021 - 2025) Analysis & Trends

For FY2022, AEON Biopharma's Return on Capital Employed [ROCE] was -79.02%, down 77.61 percentage points from FY2021.

  • Going back by year, Return on Capital Employed [ROCE] was -1.41% in FY2021.
  • The Q4 2025 figure represents the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 17.52%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 17.92%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.28%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 19.32%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 16.76%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -5.97%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 11.86%
10 AEON Biopharma 12.07 Mn -8.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -5,121.60%
Sep 30, 2025 -488.02%
Jun 30, 2025 -309.23%
Sep 30, 2023 -5,895.92%
Jun 30, 2023 -424.53%
Mar 31, 2023 -372.14%
Dec 31, 2022 -41.91%
Sep 30, 2022 -4.21%
Jun 30, 2022 -0.78%
Mar 31, 2022 -0.77%
Dec 31, 2021 -0.70%
API Access

AEON Biopharma Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AEON&period=max&api_key=YOUR_API_KEY